Disclosure Of Interests In Other Entities [Text Block]

Biocartis Group NV - Filing #3122958

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31
Disclosure of interests in other entities [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of composition of group [text block]	—	—		—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets	69,934,000 EUR	—	—	—	—	95,126,000 EUR	—	—	—	—	—
Non-current assets	44,343,000 EUR	—	—	—	—	47,354,000 EUR	—	—	—	—	—
Current liabilities	42,449,000 EUR	—	—	—	—	33,705,000 EUR	—	—	—	—	—
Non-current liabilities	102,112,000 EUR	—	—	—	—	142,672,000 EUR	—	—	—	—	—
Revenue	—	—	57,481,000 EUR	—	—	—	—	—	48,269,000 EUR	—	—
Profit (loss)	—	65,381,000 EUR	65,381,000 EUR	—	65,381,000 EUR	—	—	71,472,000 EUR	71,472,000 EUR	71,472,000 EUR	—
Comprehensive income	—	65,274,000 EUR	65,274,000 EUR	271,000 EUR	65,003,000 EUR	—	419,000 EUR	71,481,000 EUR	71,481,000 EUR	71,062,000 EUR	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—		—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	26,125,000 EUR	—	—	—	—	53,522,000 EUR	—	—	—	—	123,668,000 EUR
Tax expense (income)	—	—	240,000 EUR	—	—	—	—	—	243,000 EUR	—	—